Literature DB >> 17490437

Randomized comparison between open irrigation technology and intracardiac-echo-guided energy delivery for pulmonary vein antrum isolation: procedural parameters, outcomes, and the effect on esophageal injury.

Nassir F Marrouche1, Jens Guenther, Nathan M Segerson, Marcos Daccarett, Harald Rittger, Harald Marschang, Volker Schibgilla, Martin Schmidt, Guido Ritscher, Georg Noelker, Johannes Brachmann.   

Abstract

INTRODUCTION: We performed a prospective study to compare efficacy and safety of both open irrigation tip (OIT) technology with intracardiac echo (ICE)-guided energy delivery in patients presenting for PVAI. METHODS AND
RESULTS: Fifty-three patients presenting for PVAI were randomized to ablation using an OIT catheter (Group 1, 26 patients; temperature and power were set at 50 degrees and 50 W, respectively, with a saline pump flow rate of 30 mL/min) or radiofrequency (RF) energy delivery under ICE guidance (Group 2, 27 patients; energy was titrated based on microbubbles formation). The mean procedure time and fluoroscopy exposure were lower in Group 1 (164 +/- 42 min and 7,560 +/- 2,298 microGray m2 vs 204 +/- 47 min and 12,240 +/- 4,356 microGray m2; P = 0.005 and 0.008, respectively). Moreover, the durations of RF lesions applied per PV antrum was lower in Group 1 compared with Group 2 (5.1 +/- 2.2 min vs 9.2 +/- 3.2 min, P = 0.03, respectively). Within 24 hours after PVAI in 35.7% (all erythema) of Group 1 and 57.1% (21.4% erythema and 35.7% necrosis) of Group 2, patients' esophageal wall changes were documented. After 14 +/- 2 months of follow up, recurrences were documented in 19.2% of Group 1 and 22.2% of Group 2 patients.
CONCLUSION: Although both OIT and ICE-guided energy delivery possess a similar effect in treating AF, OIT seems to be superior in terms of achieving isolation and shortening fluoroscopy exposure. Moreover, a lower incidence of esophageal wall injury was observed utilizing OIT for PVAI.

Entities:  

Mesh:

Year:  2007        PMID: 17490437     DOI: 10.1111/j.1540-8167.2007.00879.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  18 in total

1.  Evaluation of left atrial lesions after initial and repeat atrial fibrillation ablation: lessons learned from delayed-enhancement MRI in repeat ablation procedures.

Authors:  Troy J Badger; Marcos Daccarett; Nazem W Akoum; Yaw A Adjei-Poku; Nathan S Burgon; Thomas S Haslam; Saul Kalvaitis; Suman Kuppahally; Gaston Vergara; Lori McMullen; Paul A Anderson; Eugene Kholmovski; Rob S MacLeod; Nassir F Marrouche
Journal:  Circ Arrhythm Electrophysiol       Date:  2010-03-24

Review 2.  [Nightmares in atrial fibrillation ablation--identification, management, and prevention of complications in radiofrequency ablation of atrial fibrillation].

Authors:  M Martinek; H Pürerfellner
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2007-12

3.  Esophageal injury following radiofrequency ablation for atrial fibrillation: injury classification.

Authors:  Jonathan Keshishian; Juan Young; Eric Hill; Yasser Saloum; Patrick G Brady
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-06

Review 4.  2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.

Authors:  Hugh Calkins; Karl Heinz Kuck; Riccardo Cappato; Josep Brugada; A John Camm; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; John DiMarco; James Edgerton; Kenneth Ellenbogen; Michael D Ezekowitz; David E Haines; Michel Haissaguerre; Gerhard Hindricks; Yoshito Iesaka; Warren Jackman; Jose Jalife; Pierre Jais; Jonathan Kalman; David Keane; Young-Hoon Kim; Paulus Kirchhof; George Klein; Hans Kottkamp; Koichiro Kumagai; Bruce D Lindsay; Moussa Mansour; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Douglas L Packer; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Vivek Reddy; Jeremy N Ruskin; Richard J Shemin; Hsuan-Ming Tsao; David Wilber
Journal:  J Interv Card Electrophysiol       Date:  2012-03       Impact factor: 1.900

5.  Magnetically guided irrigated gold-tip catheter ablation of persistent atrial fibrillation--techniques, procedural parameters and outcome.

Authors:  Bogdan Muntean; Klaus-Jürgen Gutleben; Johannes Heintze; Jürgen Vogt; Dieter Horstkotte; Georg Nölker
Journal:  J Interv Card Electrophysiol       Date:  2012-05-24       Impact factor: 1.900

Review 6.  Role of Echocardiography in Atrial Fibrillation Ablation.

Authors:  C Y Andrew; Allan L Klein
Journal:  J Atr Fibrillation       Date:  2011-12-20

7.  Initial feasibility testing of limited field of view magnetic resonance thermometry using a local cardiac radiofrequency coil.

Authors:  Nelly A Volland; Eugene G Kholmovski; Dennis L Parker; J Rock Hadley
Journal:  Magn Reson Med       Date:  2012-11-19       Impact factor: 4.668

Review 8.  Prevention of esophageal thermal injury during radiofrequency ablation for atrial fibrillation.

Authors:  Enzhao Liu; Michael Shehata; Tong Liu; Allen Amorn; Eugenio Cingolani; Vinod Kannarkat; Sumeet S Chugh; Xunzhang Wang
Journal:  J Interv Card Electrophysiol       Date:  2012-06-21       Impact factor: 1.900

9.  Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: implications for disease progression and response to catheter ablation.

Authors:  Christian Mahnkopf; Troy J Badger; Nathan S Burgon; Marcos Daccarett; Thomas S Haslam; Christopher T Badger; Christopher J McGann; Nazem Akoum; Eugene Kholmovski; Rob S Macleod; Nassir F Marrouche
Journal:  Heart Rhythm       Date:  2010-07-01       Impact factor: 6.343

10.  Limiting esophageal temperature in radiofrequency ablation of left atrial tachyarrhythmias results in low incidence of thermal esophageal lesions.

Authors:  Armin Sause; Osman Tutdibi; Karsten Pomsel; Wilfried Dinh; Reiner Füth; Mark Lankisch; Thomas Glosemeyer-Allhoff; Jan Janssen; Micheal Müller
Journal:  BMC Cardiovasc Disord       Date:  2010-10-26       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.